3298
Z. Moussa, D. Romo
LETTER
(9) Parsons, A. F.; Pettifer, R. M. Tetrahedron Lett. 1996, 37,
1667.
(10) Nyasse, B.; Grehn, L.; Ragnarsson, U. Chem. Commun.
1997, 1017.
T.; Jackson, J. R.; Hoffman, P. L.; Evora, P. H.; Rao, A. V.;
Molinoff, P. B.; Childers, S. R.; Ehrenkaufer, R. L. J. Med.
Chem. 1993, 36, 3707. (f) Acetamide 17: Strømgaard, K.;
Brierley, M. J.; Andersen, K.; Sløek, F. A.; Mellor, I. R.;
Usherwood, P. N. R.; Krogsgaard-Larsen, P.; Jaroszewski, J.
W. J. Med. Chem. 1999, 42, 5224. (g) Acetamide 18: Keck,
G. E.; Wager, T. T.; McHardy, S. F. Tetrahedron 1999, 55,
11755. (h) Acetamide 24: Vangapandu, S.; Jain, M.; Jain,
R.; Kaur, S.; Singh, P. P. Bioorg. Med. Chem. 2004, 12,
2501. (i) General Procedure for the Reductive Cleavage
of the Tosyl Group of Monosubstituted N-(p-Toluene-
sulfonyl) Amides as Described for Preparation of Amide
5: To a stirred solution of sulfonamide 3 (55.1 mg, 0.20
mmol) and Et3N (60 mL, 0.40 mmol) in CH2Cl2 (3.0 mL) was
added TFAA (57 mL, 0.40 mmol) dropwise via syringe.
After aliquot NMR analysis indicated complete reaction (ca.
10 min), the solvent was concentrated in vacuo and the
residue was diluted with THF (1.0 mL), cooled to –78 °C and
subsequently treated dropwise with SmI219 in THF (10.0 mL,
0.098 M, 0.98 mmol). The resulting mixture was stirred for
30 min and then quenched by filtering through a compressed
pad of silica gel. The filter pad was washed with EtOAc and
the solvent was removed in vacuo. The residue was
chromatographed (elution with 10% EtOAc–hexanes) to
afford acetamide 5 (37 mg, 85%) as a white solid, followed
by the starting material 3 (7.5 mg). The spectral data for the
isolated material was in accord with published spectral
data.21
(11) (a) Nishimura, O.; Fujino, M. Chem. Pharm. Bull. 1976, 24,
1568. (b) Fujino, M.; Wakimasu, M.; Kitada, C. Chem.
Pharm. Bull. 1981, 29, 2825. (c) Ramage, R.; Green, J.;
Blake, A. J. Tetrahedron 1991, 47, 6353.
(12) (a) Nyasse, B.; Grehn, L.; Ragnarsson, U.; Maia, H. L. S.;
Monteiro, L. S.; Leito, I.; Koppel, I.; Koppel, J. J. Chem.
Soc., Perkin Trans. 1 1995, 2025. (b) Milburn, R. R.;
Snieckus, V. Angew. Chem. Int. Ed. 2004, 43, 892.
(13) For a review on the nosyl group, see: Kan, T.; Fukuyama, T.
Chem. Commun. 2004, 353.
(14) Kong, K.; Moussa, Z.; Romo, D. Org. Lett. 2005, 7, 5127.
(15) For reviews of SmI2, see: (a) Edmonds, D. J.; Johnston, D.;
Procter, D. J. Chem. Rev. 2004, 104, 3371. (b) Kagan, H. B.
Tetrahedron 2003, 59, 10351. (c) Krief, A.; Laval, A.-M.
Chem. Rev. 1999, 99, 745. (d) Molander, G. A.; Harris, C.
R. Tetrahedron 1998, 54, 3321. (e) Skrydstrup, T. Angew.
Chem., Int. Ed. Engl. 1997, 36, 345. (f) Molander, G. A.;
Harris, C. R. Chem. Rev. 1996, 96, 307. (g) Molander, G.
A. Chem. Rev. 1992, 92, 29.
(16) (a) Knowles, H.; Parsons, A. F.; Pettifer, R. M. Synlett 1997,
271. (b) Knowles, H.; Parsons, A. F.; Pettifer, R. M.;
Rickling, S. Tetrahedron 2000, 56, 979.
(17) (a) Keck, G. E.; McHardy, S. F.; Wager, T. T. Tetrahedron
Lett. 1995, 36, 7419. (b) Chiara, J. L.; Destabel, C.; Gallego,
P.; Marco-Contelles, J. J. Org. Chem. 1996, 61, 359.
(c) Keck, G. E.; Wager, T. T.; McHardy, S. F. Tetrahedron
1999, 55, 11755.
(18) Romo, D.; Rzasa, R. M.; Shea, H. A.; Park, K.; Langenhan,
J. M.; Sun, L.; Akhiezer, A.; Liu, J. O. J. Am. Chem. Soc.
1998, 120, 12237.
(19) SmI2 was prepared according to the published procedure,
see: Imamoto, T.; Ono, M. Chem. Lett. 1987, 501.
(20) We were unable to isolate a clean sample of
bistrifluoroacetamide 6 as it underwent partial deacetylation
to acetamide 5 during chromatography.
(23) Et3N was not suitable for the tosylation of 3¢-aminoaceto-
phenone (Table 1, sulfonamide 14) as it resulted in an
inseparable mixture of 14 and its bistosylated derivative.
However, employing pyridine as a base led to exclusive
monotosylation.
(24) Substrate 8 (Table 1, entry 3) required TFAA (3 equiv) and
Et3N for complete acetylation.
(25) Reductive cleavage of the tosyl group at 23 °C led to
significantly reduced yields of trifluoroacetamide.
(26) (a) Weygand, F.; Swodenk, W. Chem. Ber. 1957, 90, 693.
(b) Newman, H. J. Org. Chem. 1965, 30, 1287. (c) Quick,
J.; Weygand, F.; Frauendorfer, E. Chem. Ber. 1970, 103,
2437. (d) Barrett, A. G. M.; Lana, J. C. A. J. Chem. Soc.,
Chem. Commun. 1978, 471. (e) Meltz, C. J. Org. Chem.
1979, 44, 573. (f) Eckstein, F. J. Org. Chem. 1979, 44,
2049. (g) Pyne, S. G. Tetrahedron Lett. 1987, 28, 4737.
(h) Bergeron, R. J.; McManis, J. J. J. Org. Chem. 1988, 53,
3108. (i) King, S. B.; Ganem, B. J. Am. Chem. Soc. 1994,
116, 562. (j) Imazawa, M.; Albanese, D.; Corcella, D.;
Landini, A.; Maia, A.; Penso, M. J. Chem. Soc., Perkin
Trans. 1 1997, 247. (k) Kudzin, Z. H.; Lyzwa, P.; Luczak,
J.; Andrijewski, G. Synthesis 1997, 44.
(21) Pache, S.; Botuha, C.; Franz, R.; Kündig, E. P.; Einhorn, J.
Helv. Chim. Acta 2000, 83, 2436.
(22) The following compounds are known and spectroscopic data
have been previously reported in the literature:
(a) Sulfonamide 3: Soeta, T.; Nagai, K.; Fujihara, H.;
Kuriyama, M.; Tomioka, K. J. Org. Chem. 2003, 68, 9723.
(b) Sulfonamide 8: Di Martino, A.; Galli, C.; Gargano, P.;
Mandolini, L. J. Chem. Soc., Perkin Trans. 2 1985, 1345.
(c) Sulfonamide 9: Moon, B.; Han, S.; Yoon, Y.; Kwon, H.
Org. Lett. 2005, 7, 1031. (d) Sulfonamide 10: Bookser, B.
C.; Bruice, T. C. J. Am. Chem. Soc. 1991, 113, 4208.
(e) Acetamide 16: Mach, R. H.; Luedtke, R. R.; Unsworth,
C. D.; Boundy, V. A.; Nowak, P. A.; Scripko, J. G.; Elder,
Synlett 2006, No. 19, 3294–3298 © Thieme Stuttgart · New York